Aman is Vice President, Global Head of Regulatory Strategy at Worldwide Clinical Trials.
Aman Khera is a well-respected global regulatory affairs leader and strategist with over 25 years of experience in the clinical research industry. Through her leadership, she has provided global regulatory strategy and development services in many therapeutic indications. Recognized for her track record in addressing the inevitable regulatory challenges in the development journey, Aman’s insights have changed the way people think about regulatory affairs, resulting in fewer late-stage surprises, smoother trials, and optimal outcomes for the development of new therapies. She is passionate about helping sponsors develop comprehensive regulatory strategies and has worked with agencies across the world. Through her commitment to diversity and inclusion in clinical research, she advises the industry on practical, yet transformative, actionable strategies. As a change maker, she is passionate about the "people" aspect of business as well as strategic operations in building, engaging and retaining teams and how this translates to successful product development and maintenance.
Aman is a Medical Biochemist by background and turned to a career within Healthcare Regulatory Affairs soon after graduating from Brunel University, she also holds an executive MBA from Quantic School of Business and Technology. Aman serves on emTRUTH’s advisory board, offering a unique perspective on the interplay of regulations, ethics, and compliance within blockchain for healthcare. She is a 2021 PharmaVOICE 100 honoree, recognized as one of the most influential and inspiring people in the life sciences industry. She is deeply involved in the clinical research community and volunteers her time with DIA, TOPRA and RAPS as well as Sikhs in Clinical Research. She is credited with multiple published articles, interviews, and presentations.